CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 2,367 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05277896
NCT05277896Phase 4Completed

The Randomized Trial of Sedative Choice for Intubation

Vanderbilt University Medical Center·interventional·Posted Mar 14, 2022·Updated Mar 25, 2026

In Brief

A Phase 4 clinical trial evaluating Ketamine and Etomidate for Acute Respiratory Failure. Completed, enrolled 2,367 participants across 6 sites.

Detailed Summary

Among critically ill adults undergoing emergency tracheal intubation, one in five experience hypotension, cardiac arrest, or death. The sedatives used to rapidly induce anesthesia for emergency tracheal intubation have been hypothesized to effect cardiovascular complications and patient outcomes, but the optimal sedative medication for intubation of critically ill adults remains unknown. Ketamine and etomidate are the two most commonly used sedatives during intubation of critically ill adults. Data from a randomized clinical trial are urgently needed to determine the effect of ketamine versus etomidate on cardiovascular complications and clinical outcomes of emergency tracheal intubation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
2023202420252026
First PostedMar 14, 2022
Enrollment StartApr 6, 2022
Primary CompletionSep 6, 2025
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 4.3 years ago

Interventions

Ketaminedrug

Intravenous ketamine as the sedative for induction of anesthesia during emergency tracheal intubation

Etomidatedrug

Intravenous etomidate as the sedative for induction of anesthesia during emergency tracheal intubation